About SR17Direct
Harm Reduction Needs Better Tools
Millions of people are navigating opioid and kratom dependence with inadequate support. SR17Direct exists to make SR-17018 — one of the most promising compounds in withdrawal research — accessible to the people who need it most.
For Research Use Only
All products sold by SR17Direct are analytical reference materials intended solely for laboratory and research applications. They are not for human or veterinary consumption and are not drugs, dietary supplements, or medical products. Nothing on this site is medical advice or a recommendation to use any substance to treat, diagnose, cure, or prevent any condition.
Our Mission
Real People. Real Withdrawal. Not Enough Options.
The harm reduction community has long known that people tapering off kratom, 7-OH, or opioids are largely on their own. Standard medications weren't designed for their situation. Buprenorphine locks in tolerance. Methadone carries serious overdose risk. Cold turkey is brutal and often fails. The gap between what exists and what people actually need is enormous.
SR-17018 emerged from preclinical research as something genuinely different — a G-protein biased mu-opioid agonist that appears to suppress withdrawal without reinforcing the underlying dependence cycle. Whether you're a researcher studying the mechanism or someone managing your own taper, that distinction matters.
We started SR17Direct because access to this compound was nearly impossible for the communities who could benefit from it most. That's what we're here to fix.
Every person trapped in the cycle of dependence deserves to know that science is working on better solutions. SR17Direct exists to make those solutions accessible.
— The SR17Direct Team
Our Story
Why SR17Direct Exists
Harm reduction is only as good as the tools available. We're working to close the gap.
The Problem
A Crisis Without Adequate Tools
Millions of people worldwide struggle with opioid dependence. Existing treatments — while valuable — often substitute one dependency for another, preserve tolerance, or carry significant induction risks. The research community needed better tools to study novel approaches.
The Science
A Different Kind of Compound
In 2019, researchers at RTI International published landmark findings on SR-17018: a G-protein biased mu-opioid receptor agonist that reversed morphine tolerance while preventing withdrawal in preclinical models — a combination no existing MAT agent had demonstrated.
The Gap
Access Was the Bottleneck
Despite growing research interest, obtaining high-purity SR-17018 remained difficult. Researchers faced long lead times, inconsistent quality, and limited availability. The science was advancing faster than the supply chain could support.
SR17Direct
Bridging Research and Availability
SR17Direct was founded to solve that problem. We partnered with certified synthesis laboratories to provide consistently pure, analytically verified SR-17018 with full documentation — making it accessible to the researchers who need it most.
What We Stand For
Our Core Values
Harm reduction isn't a side effect of what we do — it's the whole point.
Uncompromising Purity
Every batch is independently verified by certified laboratories using HPLC and NMR spectroscopy. We publish full certificates of analysis because trust is built on evidence, not promises.
Scientific Rigor
We approach our work with the same discipline expected in a research setting. Batch traceability, precise documentation, and reproducible quality are non-negotiable standards.
Radical Transparency
Our lab results are publicly available. We believe researchers deserve complete analytical data to verify what they receive — not marketing claims, but verifiable numbers.
Purpose Over Profit
We exist because dependence destroys lives. Every order we fulfill supports research into a compound that may help people reclaim their freedom. That purpose drives every decision we make.
Privacy & Discretion
We accept cryptocurrency payments and ship in unmarked packaging. Your research is your business. We take privacy seriously because we understand the sensitivity of this work.
Accessible Research
Groundbreaking research shouldn't be gated by prohibitive costs or opaque supply chains. We provide research-grade SR-17018 at fair prices with clear, honest communication.
Who We Serve
For Anyone Trying to Find a Better Way
Our community spans academic researchers, harm reduction practitioners, independent investigators, and people navigating their own dependence journey. What unites them is a shared frustration with the status quo — and a belief that something better is possible. We don't judge why you're here. We just make sure you have access to quality materials, honest information, and the documentation to use them safely.
People Managing Withdrawal
Tapering off kratom, 7-OH, or opioids and looking for a harm reduction tool with a different mechanism than what's currently available.
Independent Researchers
Investigating tolerance reversal, G-protein biased agonism, or withdrawal mechanisms — with access to documented, verified material.
Harm Reduction Practitioners
Supporting clients or communities navigating dependence, seeking novel approaches beyond the standard MAT toolkit.
You Shouldn't Have to Do This Alone
Whether you're researching, tapering, or supporting someone who is — we're here. SR-17018 with full documentation, fair pricing, and people on the other end who actually understand what you're going through. Harm reduction isn't a category for us. It's the reason we exist.
For Research Use Only. SR-17018 is supplied exclusively for legitimate scientific and academic research. Not intended for human or veterinary use, diagnosis, or treatment. Not FDA approved. Not for consumption.